0Q1N.LSE Pfizer Inc.

Healthcare Commercial Services & Supplies London Exchange
31.25 USD
Close of Nov 3, 2026
20.75 31.45
Market cap
USD 178B
P/E
22.5x
P/B
2.04x
ROE
5.7%
Dividend yield
5.50%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0Q1N.LSE undervalued?

Graham number
Price31.25
Graham value21.91
Premium42.6%

0Q1N.LSE trades 42.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pfizer Inc. fundamental analysis

No fundamental analysis for Pfizer Inc. yet.

Pfizer Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, …

Full company profile